A Goette

Summary

Affiliation: Otto-von-Guericke University
Country: Germany

Publications

  1. ncbi Signal transduction systems and atrial fibrillation
    Andreas Goette
    Division of Cardiology, Department of Internal Medicine, University Hospital Magdeburg, Leipzigerstr 44, 39120 Magdeburg, Germany
    Cardiovasc Res 54:247-58. 2002
  2. ncbi Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?
    Andreas Goette
    University Hospital Magdeburg, Division of Cardiology, Leipziger Str 44, 39120 Magdeburg, Germany
    Circulation 108:2446-9. 2003
  3. ncbi Pacing to prevent atrial fibrillation after coronary artery bypass grafting. What works, what doesn't: insights from Bachmann's Bundle pacing
    Andreas Goette
    Department of Internal Medicine, Division of Cardiology, University Hospital Magdeburg, Leipzigerstrasse 44, 39120 Magdeburg, Germany
    Card Electrophysiol Rev 7:154-7. 2003
  4. ncbi Effect of physical exercise on platelet activity and the von-Willebrand-factor in patients with persistent lone atrial fibrillation
    Andreas Goette
    Department of Internal Medicine, University Hospital Magdeburg, Magdeburg, Germany
    J Interv Card Electrophysiol 10:139-46. 2004
  5. ncbi Nonchannel drug targets in atrial fibrillation
    Andreas Goette
    Division of Cardiology, Otto von Guericke University Magdeburg, Leipzigerstrasse 44, 39120 Magdeburg, Germany
    Pharmacol Ther 102:17-36. 2004
  6. ncbi Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling)
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Leipziger Str 44, Magdeburg, Germany
    Curr Opin Pharmacol 7:219-24. 2007
  7. ncbi Pneumomediastinum, subcutaneous emphysema and respiratory arrest after "mediastinal intubation"
    Andreas Goette
    Division of Cardiology and Intensive Care Medicine, University Hospital Magdeburg, Germany
    Resuscitation 72:340-1. 2007
  8. ncbi Aortic thrombus and pulmonary embolism in a patient with hyperhomocysteinemia
    Andreas Goette
    University Hospital Magdeburg, Division of Cardiology, Germany
    Nat Clin Pract Cardiovasc Med 3:396-9; quiz following 399. 2006
  9. ncbi [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker]
    A Goette
    , Angiologie und Pneumologie,
    Dtsch Med Wochenschr 131:S103-7. 2006
  10. ncbi [Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]
    A Goette
    Otto von Guericke Universitätsklinik Magdeburg, Klinik fur Kardiologie, Angiologie und Pneumologie, Leipziger Str 44, 39120 Magdeburg, Germany
    Z Kardiol 93:864-77. 2004

Collaborators

Detail Information

Publications54

  1. ncbi Signal transduction systems and atrial fibrillation
    Andreas Goette
    Division of Cardiology, Department of Internal Medicine, University Hospital Magdeburg, Leipzigerstr 44, 39120 Magdeburg, Germany
    Cardiovasc Res 54:247-58. 2002
    ..Most of these changes seem to be related to activation of signal transduction systems at the molecular atrial level. This review will describe the role and regulation of different signal transduction systems in fibrillating atria...
  2. ncbi Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?
    Andreas Goette
    University Hospital Magdeburg, Division of Cardiology, Leipziger Str 44, 39120 Magdeburg, Germany
    Circulation 108:2446-9. 2003
    ..Studies suggest that myocardial progenitor cells invade atrial tissue. So far it is unclear, however, whether an atrial disease per se affects circulating HPCs...
  3. ncbi Pacing to prevent atrial fibrillation after coronary artery bypass grafting. What works, what doesn't: insights from Bachmann's Bundle pacing
    Andreas Goette
    Department of Internal Medicine, Division of Cardiology, University Hospital Magdeburg, Leipzigerstrasse 44, 39120 Magdeburg, Germany
    Card Electrophysiol Rev 7:154-7. 2003
    ..However, BB offers favorable pacing capabilities and is less arrhythmogenic compared to right atrial pacing during the postoperative period...
  4. ncbi Effect of physical exercise on platelet activity and the von-Willebrand-factor in patients with persistent lone atrial fibrillation
    Andreas Goette
    Department of Internal Medicine, University Hospital Magdeburg, Magdeburg, Germany
    J Interv Card Electrophysiol 10:139-46. 2004
    ..The purpose of this study was to assess the effect of physical exercise on platelet activity, thrombin generation, and levels of von-Willebrand-factor in patients with persistent AF...
  5. ncbi Nonchannel drug targets in atrial fibrillation
    Andreas Goette
    Division of Cardiology, Otto von Guericke University Magdeburg, Leipzigerstrasse 44, 39120 Magdeburg, Germany
    Pharmacol Ther 102:17-36. 2004
    ..Therefore, this review will highlight some novel "nonchannel drug targets" for AF therapy...
  6. ncbi Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling)
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Leipziger Str 44, Magdeburg, Germany
    Curr Opin Pharmacol 7:219-24. 2007
    ..Elucidating the signalling pathways responsible for the process of structural atrial remodeling has helped to define novel non-ion channel drug targets for atrial fibrillation...
  7. ncbi Pneumomediastinum, subcutaneous emphysema and respiratory arrest after "mediastinal intubation"
    Andreas Goette
    Division of Cardiology and Intensive Care Medicine, University Hospital Magdeburg, Germany
    Resuscitation 72:340-1. 2007
  8. ncbi Aortic thrombus and pulmonary embolism in a patient with hyperhomocysteinemia
    Andreas Goette
    University Hospital Magdeburg, Division of Cardiology, Germany
    Nat Clin Pract Cardiovasc Med 3:396-9; quiz following 399. 2006
    ..Further laboratory tests revealed elevated plasma levels of homocysteine, asymmetric dimethylarginine, symmetric dimethylarginine and 8-isoprostaglandin F2alpha...
  9. ncbi [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker]
    A Goette
    , Angiologie und Pneumologie,
    Dtsch Med Wochenschr 131:S103-7. 2006
  10. ncbi [Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]
    A Goette
    Otto von Guericke Universitätsklinik Magdeburg, Klinik fur Kardiologie, Angiologie und Pneumologie, Leipziger Str 44, 39120 Magdeburg, Germany
    Z Kardiol 93:864-77. 2004
    ..This review highlights the underlying molecular biology of atrial fibrillation, which may also be relevant for AF therapy...
  11. ncbi [Morphological remodeling in atrial fibrillation]
    Andreas Goette
    Klinik fur Kardiologie, Angiologie und Pneumologie, Otto von Guericke Universitätsklinik, Magdeburg
    Herz 31:101-7; quiz 142-3. 2006
    ..This highly interesting methodology may be helpful to restore electrical conduction in fibrotic cardiac tissue...
  12. ncbi Cigarette smoking induces atrial fibrosis in humans via nicotine
    Andreas Goette
    Institute of Experimental Internal Medicine, Division of Cardiology, Department of Cardiovascular Surgery, University Hospital Magdeburg, Magdeburg, Germany
    Heart 93:1056-63. 2007
    ..Cigarette smoking (CS) promotes endothelial dysfunction and atherosclerosis in the vascular bed. The impact of smoking on atrial myocardium is not defined in humans...
  13. ncbi Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design
    Andreas Goette
    Division of Cardiology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany
    Clin Drug Investig 27:697-705. 2007
    ..Furthermore, tele-ECG recordings will be transmitted in any case of symptomatic AF. The present paper summarises the rationale and design of the ANTIPAF trial...
  14. ncbi Increased expression of P-selectin in patients with chronic atrial fibrillation
    A Goette
    University Hospital Magdeburg, Department of Internal Medicine, Division of Cardiology, Leipzigerstr 44, 39120 Magdeburg, Germany
    Pacing Clin Electrophysiol 23:1872-5. 2000
    ..In contrast, increased ventricular rate and elevated atrial pressure alone had no effect on platelet activity. Further studies are needed to determine if platelet ADP receptor inhibitors offer a therapeutic benefit in patients with AF...
  15. ncbi Case report: severe skin burn at the site of the indifferent electrode after radiofrequency catheter ablation of typical atrial flutter
    A Goette
    University Hospital Magdeburg, Department of Internal Medicine, Division of Cardiology, Germany
    J Interv Card Electrophysiol 5:337-40. 2001
    ..Long RF energy application times, high-power settings, and heavy sedation may have contributed to the observed severity of skin damage...
  16. ncbi Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Leipziger Street 44, 39120 Magdeburg Germany
    Europace 8:157-60. 2006
    ..We sought to determine the cardiac uptake of PC in patients with moderate-to-severe congestive heart failure (CHF) scheduled for cardiac resynchronization therapy...
  17. ncbi Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Leipzigerstr 44, Magdeburg 39120, Germany
    Europace 10:238-41. 2008
    ..Therefore, this review will highlight on the basic knowledge of signal transduction and electrophysiological effects of angiotensin II, which may have an impact on the occurrence of cardiac arrhythmia...
  18. ncbi Calpains and cytokines in fibrillating human atria
    Andreas Goette
    Division of Cardiology, Department of Internal Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany
    Am J Physiol Heart Circ Physiol 283:H264-72. 2002
    ..In conclusion, atria of patients with permanent AF show evidence of calpain I activation that might contribute to structural remodeling and contractile dysfunction, whereas there is no evidence of activation of tissue cytokines...
  19. ncbi Pacing of Bachmann's bundle after coronary artery bypass grafting
    Andreas Goette
    Department of Internal Medicine, University Hospital Magdeburg, Germany
    Pacing Clin Electrophysiol 25:1072-8. 2002
    ..However, the Bachmann's bundle offers favorable capabilities for postoperative a trial pacing, and thus it is a preferable site for electrode placement if postoperative atrial pacing is required...
  20. ncbi Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
    A Goette
    University Hospital Magdeburg, Division of Cardiology, Germany
    Circulation 101:2678-81. 2000
    ..The purpose of this study was to determine the atrial expression of angiotensin II type 1 and type 2 receptors (AT(1)-R and AT(2)-R) in patients with AF...
  21. ncbi Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation
    A Bukowska
    Institute of Experimental Internal Medicine, University Hospital Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany
    Cell Mol Life Sci 63:333-42. 2006
    ..Atrial tachyarrhythmia causes atrial hypertrophy by activation of the CnA signal pathway, which thereby contributes to structural remodeling of human atria...
  22. ncbi Changes in AV node conduction curves following slow pathway modification
    J C Geller
    Division of Cardiology, Department of Medicine, University Hospitals, Otto von Guericke University, Leipzigerstr 44, D 39120 Magdeburg, Germany
    Pacing Clin Electrophysiol 23:1651-60. 2000
    ....
  23. ncbi Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillation
    Andreas Goette
    Department of Cardiology, Otto von Guericke University Hospital, Magdeburg, Germany
    Clin Drug Investig 28:565-72. 2008
    ....
  24. ncbi Expression and activity of ectopeptidases in fibrillating human atria
    U Lendeckel
    Institute of Experimental Internal Medicine, University Hospital Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    J Mol Cell Cardiol 33:1273-81. 2001
    ..In conclusion, atrial bradykinin metabolizing activities are significantly altered during AF in humans. The observed alterations in ectopeptidase expression/activity may play a role in the structural remodeling of fibrillating atria...
  25. ncbi Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation
    Matthias Hammwohner
    Division of Cardiology, Department of Internal Medicine, University Hospital Magdeburg, Leipzigerstr 44, 39120 Magdeburg, Germany
    Exp Biol Med (Maywood) 232:581-9. 2007
    ..In addition to hsCRP, MCP-1 and VCAM may serve as new biomarkers, which may help to identify patients with an increased risk for thromboembolic events...
  26. ncbi Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression
    Andreas Goette
    Division of Cardiology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany
    Circulation 117:732-42. 2008
    ....
  27. ncbi Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia
    Lorenz Schild
    Institute of Clinical Chemistry, Department of Pathobiochemistry, Otto-von-Guericke University Magdeburg, and Division of Cardiology, University Hospital Magdeburg, Germany
    Biochim Biophys Acta 1762:608-15. 2006
    ..The in vitro pacing model presented here reflects changes occurring during tachycardia and, thus, allows functional analyses of the signaling pathways involved...
  28. ncbi Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation
    Christoph Rocken
    Department of Pathology, Otto von Guericke University, Magdeburg, Germany
    Circulation 106:2091-7. 2002
    ..Structural changes, like atrial fibrosis, may increase the likelihood of atrial fibrillation (AF) occurring in response to triggering events. The influence of isolated atrial amyloidosis (IAA) is largely unknown...
  29. ncbi Expression of opioid receptor subtypes and their ligands in fibrillating human atria
    Uwe Lendeckel
    Institute of Experimental Internal Medicine, Otto von Magdeburg, Magdeburg, Germany
    Pacing Clin Electrophysiol 28:S275-9. 2005
    ..Persistent AF is associated with the down-regulation of the opioid receptor/ligand expression. This suggests a loss of protective capacity in the fibrillating atrial tissue, resulting in an ultrastructural remodeling of atrial myocytes...
  30. ncbi Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Leipziger Str. 44, 39120, Magdeburg Germany
    Cardiovasc Res 54:390-6. 2002
    ..The results support the importance of P-wave duration as a predictor of post-operative AF, and explain the increased prevalence of AF in elderly patients after OHS...
  31. ncbi Characterization of left ventricular activation in patients with heart failure and left bundle-branch block
    Angelo Auricchio
    Division of Cardiology, University Hospital, Leipzigerstrasse 44, D 39120 Magdeburg, Germany
    Circulation 109:1133-9. 2004
    ....
  32. ncbi Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
    Alicja Bukowska
    University Hospital Magdeburg, Institute of Experimental Internal Medicine, Leipzigerstrasse 44, 39120 Magdeburg, Germany
    Exp Biol Med (Maywood) 233:558-74. 2008
    ..This study demonstrates that calcium inward current via L-type calcium channels contributes to oxidative stress and increased expression of oxidative stress markers and adhesion molecules during cardiac tachyarrhythmia...
  33. ncbi The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Germany
    Int J Cardiol 143:264-70. 2010
    ..However, mobilization of progenitor cells by application of G-CSF gives inconsistent clinical effects. The aim of the present study was to assess pathophysiologic effects of progenitor cell mobilization...
  34. ncbi Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria
    Marco Arndt
    Institute of Experimental Internal Medicine, University Hospital Magdeburg, Germany
    Circulation 105:720-5. 2002
    ..The purpose of the present study was to determine whether structural remodeling of the atria during atrial fibrillation (AF) is associated with altered ADAM expression...
  35. ncbi Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation
    Alicja Bukowska
    Institute of Experimental Internal Medicine, University Hospital Magdeburg, Magdeburg, Germany
    Cardiovasc Pathol 19:e51-60. 2010
    ..This study was designed to determine the endocardial expression of eNOS in atrial tissue samples from patients with and without AF...
  36. ncbi Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney
    Alicja Bukowska
    Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Germany
    Europace 10:1212-7. 2008
    ..So far, it is unknown whether AF itself influences renal function. The aim of the present study was to determine the impact of AF on renal gene expression in a closed chest rapid atrial pacing model...
  37. ncbi New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation
    Matthias Hammwohner
    University Hospital Magdeburg, Division of Cardiology, Magdeburg, Germany
    Curr Vasc Pharmacol 5:211-9. 2007
    ..e. direct thrombin inhibitors (DTI), synthetic polysaccharides (factor Xa Inhibitors), and others are discussed, and their possible future role in the treatment of AF is evaluated...
  38. ncbi New drugs for atrial fibrillation
    Matthias Hammwohner
    Division of Cardiology, University Hospital Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    J Interv Card Electrophysiol 23:15-21. 2008
    ..Furthermore, novel anticoagulants are now clinically studied. This review briefly summarizes new developments in the pharmacotherapy for AF...
  39. ncbi Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Otto von Guericke University, Leipzigerstr 44, 39120 Magdeburg, Germany
    Eur Heart J 30:1411-20. 2009
    ..However, in a large proportion of these patients, significant coronary artery disease is excluded by coronary angiography. Here we explored the potential underlying mechanism of these events...
  40. ncbi G-CSF-induced mobilization of CD34(+) progenitor cells and proarrhythmic effects in patients with severe coronary artery disease
    Oliver Wolfram
    Division of Cardiology, University Hospital Magdeburg, Magdeburg, Germany
    Pacing Clin Electrophysiol 30:S166-9. 2007
    ..The in vivo mobilization of endothelial progenitor cells (EPCs) and the possible proarrhythmic effects in patients with severe coronary artery disease (CAD) and inducible ischemia have not been described...
  41. ncbi Proteomics in myocardial diseases
    Alicja Bukowska
    Division of Cardiology, Institute of Experimental Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    Pathol Res Pract 200:135-45. 2004
    ..This review will summarize the present knowledge about the use of proteome analysis in myocardial diseases...
  42. ncbi Performance and survival of transvenous defibrillation leads: need for a European data registry
    Andreas Goette
    Division of Cardiology, University Hospital Magdeburg, Magdeburg, Germany
    Europace 11:31-4. 2009
    ..One current initiative of the European Heart Rhythm Association is to initiate and develop a Europe-wide registry to monitor, over a prolonged follow-up period, the performance of ICDs and ICD leads...
  43. ncbi Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation
    Matthias Hammwohner
    Division of Cardiology, University Hospital Magdeburg, Germany
    J Cardiovasc Pharmacol 52:18-27. 2008
    ..Thus, novel anticoagulants or hybrid therapy with a combination of anticoagulants with inhibitors of endocardial remodelling like angiotensin II receptor blockers appear to be attractive future perspective approaches...
  44. ncbi Tachycardia-induced remodeling: atria and ventricles take a different route
    Andreas Goette
    Cardiovasc Res 63:194-5. 2004
  45. ncbi Outcome parameters for trials in atrial fibrillation: executive summary
    Paulus Kirchhof
    Department of Cardiology and Angiology, University Hospital Munster, Albert Schweitzer Strasse 33, D 48149 Munster, Germany
    Eur Heart J 28:2803-17. 2007
    ..In addition to a careful selection of a relevant primary outcome parameter, coverage of outcomes in all major domains of AF-related morbidity and mortality is desirable for any clinical trial in AF...
  46. ncbi Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke
    Hua Cai
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA
    Circulation 106:2854-8. 2002
    ..These data suggest that organized atrial contraction is needed to maintain normal endocardial expression of NOS. It is likely that loss of this antithrombotic enzyme contributes to the thromboembolic phenomena commonly observed in AF...
  47. ncbi Blockade of atrial angiotensin II type 1 receptors: a novel antiarrhythmic strategy to prevent atrial fibrillation?
    Helmut U Klein
    J Am Coll Cardiol 41:2205-6. 2003
  48. ncbi Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
    Andreas Goette
    J Am Coll Cardiol 43:2363; author reply 2363-4. 2004
  49. ncbi Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"?
    Andreas Goette
    Eur Heart J 25:1185-6. 2004
  50. ncbi [German Competence Network on Atrial Fibrillation (AFNET). A nationwide cooperation for better research and patient care]
    Angelika Leute
    Kompetenznetz Vorhofflimmern, Universitatsklinikum Munster, Munster, Germany
    Med Klin (Munich) 101:662-6. 2006
    ..Experimental basic research projects are focusing on different aspects of atrial remodeling in order to find out in which way the molecular mechanisms can be manipulated by new methods of treatment. First results are presented...
  51. ncbi Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation
    Andreas Goette
    Eur Heart J 27:2034-5. 2006
  52. ncbi Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
    Paulus Kirchhof
    Department of Cardiology and Angiology, University Hospital Munster, Albert Schweitzer Strasse 33, D 48149 Munster, Germany
    Europace 9:1006-23. 2007
    ..In addition to a careful selection of a relevant primary outcome parameter, coverage of outcomes in all major domains of AF-related morbidity and mortality is desirable for any clinical trial in AF...